Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399)

China flag China · Delayed Price · Currency is CNY
9.84
0.00 (0.00%)
Sep 9, 2024, 1:35 PM CST
-19.28%
Market Cap 12.87B
Revenue (ttm) 5.57B
Net Income (ttm) -242.92M
Shares Out 1.47B
EPS (ttm) -0.17
PE Ratio n/a
Forward PE 20.14
Dividend n/a
Ex-Dividend Date n/a
Volume 1,845,300
Open 10.04
Previous Close 9.84
Day's Range 9.78 - 10.04
52-Week Range 6.89 - 12.97
Beta 0.43
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Shenzhen Hepalink Pharmaceutical Group

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished dose pharmaceutical products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium A... [Read more]

Sector Healthcare
Founded 1998
Employees 2,080
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.